SARS CoV 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Convalescent Plasma Therapy for Hospitalized Patients With COVID-19
Recruiting
  • COVID-19
  • +5 more
  • Convalescent plasma
  • Standard of care
  • Campo Largo, Paraná, Brazil
    Maternidade e Cirurgia Nossa Senhora do Rocio/ SA - Hospital do
2021-10-12
Oct 12, 2021
U
Description of a Cohort of COVID Patients With a Circulating Anticoagulant
Recruiting
  • SARS-COV-2
    • Strasbourg, France
      Service de Médecine Interne et d'Immunologie Clinique - Hôpitaux
    2021-10-06
    Oct 6, 2021
    M
    A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
    Recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Birmingham, Alabama
    • +78 more
    2021-10-12
    Oct 12, 2021
    C
    SARS-CoV-2 Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients
    Recruiting
    • SARS-CoV-2
    • COVID-19
    • ELISA POCT vs RT-PCR
    • Monaco, Monaco
      Centre National de Depistage - Espace Leo Ferre
    2021-10-07
    Oct 7, 2021
    U
    Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy
    Active, not recruiting
    • SARS-CoV-2
      • Bern, Switzerland
        Guido Beldi
      2021-10-11
      Oct 11, 2021
      U
      Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)
      Active, not recruiting
      • SARS-CoV-2
      • COVID-19
      • POCT
      • Wilrijk, Antwerp, Belgium
        Niels Adriaenssens
      2021-10-04
      Oct 4, 2021
      S
      Sero-prevalence COVID-19 Among Belgian Children
      Recruiting
      • SARS-CoV-2
      • +2 more
        • Brussels, Belgium
          Sciensano
        2021-10-01
        Oct 1, 2021
        U
        Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
        Recruiting
        • Pneumonia, Viral
        • SARS-Cov-2
          • Montpellier, France
          • +1 more
          2021-10-07
          Oct 7, 2021
          T
          Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
          Recruiting
          • SARS-Cov-2
          • COVID-19
          • Angiotensin Receptor Blockers
          • Placebo
          • Camperdown, New South Wales, Australia
          • +18 more
          2021-10-05
          Oct 5, 2021
          T
          Azithromycin for COVID-19 Treatment in Outpatients Nationwide - 2021
          Terminated
          Has Results
          • COVID-19
          • SARS-CoV-2
          • San Francisco, California
            University of California San Francisco
          2021-10-05
          Oct 5, 2021
          U
          Slovenian National COVID-19 Prevalence Study - 2020
          Completed
          • COVID-19
          • SARS-CoV-2
          • NO intervention planned due to the observational study design - only a diagnostic testing
          • Ljubljana, Slovenia
            University of Ljubljana
          2021-09-28
          Sep 28, 2021
          U
          Effect of COVID-19 on Platelet Aggregation
          Recruiting
          • COVID-19
          • SARS-CoV-2
          • venipuncture in peripheral vein
          • Sao Paulo, Brazil
            Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
          2021-10-04
          Oct 4, 2021
          M
          Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
          Recruiting
          • SARS-CoV-2
            • Durham, North Carolina
              IQVIA Call Center for United States and Canada
            2021-09-27
            Sep 27, 2021
            S
            COVID-19 Among Healthcare Workers in Belgian Hospitals - 2021
            Completed
            • SARS-CoV-2
            • COVID-19
              • Brussels, Belgium
                Sciensano
              2021-10-01
              Oct 1, 2021
              C
              A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19 - 2021
              Completed
              • Coronavirus
              • +3 more
              • CVnCoV Vaccine
              • Brussels, Belgium
              • +3 more
              2021-10-01
              Oct 1, 2021
              U
              National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units - 2021
              Completed
              • SARS-CoV-2
              • Covid19
              • observation
              • Angers, France
                Angers University Hospital
              2021-09-30
              Sep 30, 2021
              M
              Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
              Active, not recruiting
              • SARS-CoV-2
              • Biological: mRNA-1273
              • +2 more
              • Savannah, Georgia
              • +7 more
              2021-09-28
              Sep 28, 2021
              U
              Asymptomatic SARS-CoV-2 Detection in Children
              Recruiting
              • Covid19
              • SARS-CoV-2
                • Birmingham, Alabama
                • +4 more
                2021-09-28
                Sep 28, 2021
                U
                Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample - 2021
                Completed
                • Covid19
                • SARS-CoV-2
                • TestNPass
                • Grenoble cedex 9, France
                  Grenoble University Hospital
                2021-09-28
                Sep 28, 2021
                A
                Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) - 2021
                Completed
                • Covid19
                • SARS-CoV-2
                • Blood count
                • +6 more
                • Paris, Île-de-France, France
                  Hôpital Cochin
                2021-09-27
                Sep 27, 2021
                F
                EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
                Recruiting
                • SARS-CoV-2
                • Half dose of ChAdOx1 nCoV-19 (AZD1222)
                • Standard dose of ChAdOx1 nCoV-19 (AZD1222)
                • Vitória, Espirito Santo, Brazil
                  Federal University of Espirito Santo
                2021-09-24
                Sep 24, 2021
                M
                Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland - 2021
                Completed
                • SARS-CoV-2
                • Survey
                • Białystok, Poland
                • +1 more
                2021-09-22
                Sep 22, 2021
                O
                Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19
                Recruiting
                • SARS-CoV-2
                • Winston-Salem, North Carolina
                • +1 more
                2021-09-18
                Sep 18, 2021
                R
                Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease - 2021
                Terminated
                • Acute Respiratory Distress Syndrome
                • +4 more
                • Valsartan (Diovan)
                • Placebo oral tablet
                • 's-Hertogenbosch, Netherlands
                • +6 more
                2021-09-19
                Sep 19, 2021
                S
                Study to Assess Safety, Reactogenicity and Immunogenicity of the VACINA RNA MCTI CIMATEC HDT Vaccine Against COVID-19
                Not yet recruiting
                • SARS-CoV-2
                • Cohort 1 VACINA RNA MCTI CIMATEC HDT vaccine
                • +3 more
                • (no location specified)
                2021-09-21
                Sep 21, 2021